{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:32:53Z","timestamp":1782513173174,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","award":["0904348-ARD-03\/2009"],"award-info":[{"award-number":["0904348-ARD-03\/2009"]}],"id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","award":["473365\/2009-0"],"award-info":[{"award-number":["473365\/2009-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FINEP research grant \u201cRede Instituto Brasileiro de Neuroci\u00eancia","award":["01.06.0842-00"],"award-info":[{"award-number":["01.06.0842-00"]}]},{"name":"FIPE\/UFSM"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.pbb.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T15:47:28Z","timestamp":1326469648000},"page":"307-310","source":"Crossref","is-referenced-by-count":26,"title":["Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine"],"prefix":"10.1016","volume":"101","author":[{"given":"Alcindo","family":"Busanello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R.","family":"Peroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssie H.","family":"Sudati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaiana P.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro de S.","family":"Prestes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o B.T.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselei","family":"Fachinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilda B.V.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2012.01.007_bb0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2004.04.003","article-title":"Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia","volume":"47","author":"Ab\u00edlio","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.01.007_bb0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.neuroscience.2003.08.058","article-title":"Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats","volume":"122","author":"Andreassen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2012.01.007_bb0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brainresrev.2006.04.004","article-title":"Resveratrol-a boon for treating Alzheimer's disease?","volume":"52","author":"Anekonda","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2012.01.007_bb0025","series-title":"Experiments in personality","first-page":"76","article-title":"Experiments in psychogenetics","author":"Broadhurst","year":"1960"},{"key":"10.1016\/j.pbb.2012.01.007_bb0030","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1530-0277.2009.00989.x","article-title":"The biological responses to resveratrol and other polyphenols from alcoholic beverages","volume":"33","author":"Brown","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.brainresbull.2004.09.006","article-title":"Effects on age on orofacial dyskinesia reserpine-induced and possible protection of diphenyl-diselenide","volume":"64","author":"Burger","year":"2004","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2012.01.007_bb0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.pbb.2005.05.002","article-title":"Ebselen attenuates haloperidol-induced orofacial dyskinesia and oxidative stress in rat brain","volume":"81","author":"Burger","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.01.007_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2004.10.038","article-title":"Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats","volume":"1031","author":"Burger","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/FBP.0b013e328341e9b4","article-title":"Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice","volume":"22","author":"Busanello","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0166-2236(86)90035-4","article-title":"Free radical and tardive dyskinesia","volume":"9","author":"Cadet","year":"1986","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2012.01.007_bb0060","series-title":"Handbook of schizophrenia: the neurochemistry and pharmacology of schizophrenia","first-page":"425","article-title":"Tardive dyskinesia and Schizophrenic burnout: the possible involvement of cytotoxic free radicals","author":"Cadet","year":"1987"},{"key":"10.1016\/j.pbb.2012.01.007_bb0065","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s11064-008-9775-9","article-title":"Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity","volume":"33","author":"Calabrese","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0070","first-page":"88","article-title":"Tardive dyskinesia: reversible and irreversible","volume":"2","author":"Casey","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.01.007_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200900437","article-title":"Resveratrol bioavailability and toxicity in humans","volume":"54","author":"Cottart","year":"2010","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1192\/bjp.122.4.395","article-title":"Persistent dyskinesia","volume":"122","author":"Crane","year":"1973","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pbb.2012.01.007_bb0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.pbb.2012.01.007_bb0090","doi-asserted-by":"crossref","unstructured":"Di Liberto V, M\u00e4kel\u00e4 J, Korhonen L, Olivieri M, Tselykh T, M\u00e4lki\u00e4 A, et al. Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice. Neuropharmacology 2012;62:1011-8.","DOI":"10.1016\/j.neuropharm.2011.10.010"},{"key":"10.1016\/j.pbb.2012.01.007_bb0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0031-6997(25)06933-9","article-title":"Pathogenesis, prevention and treatment of neuroleptic-induced movement disorders","volume":"47","author":"Ebadi","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pbb.2012.01.007_bb0100","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.pbb.2005.05.001","article-title":"High fat diet increases the incidence of orofacial dyskinesia and oxidative stress in specific brain regions of rats","volume":"81","author":"Fachinetto","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2012.01.007_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00213-007-0831-y","article-title":"Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats","volume":"194","author":"Fachinetto","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2012.01.007_bb0110","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2007.06.028","article-title":"Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter","volume":"31","author":"Fachinetto","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2012.01.007_bb0115","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.neuropharm.2005.01.014","article-title":"Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity","volume":"48","author":"Faria","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.01.007_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/jnr.10315","article-title":"Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells","volume":"70","author":"G\u00e9linas","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","article-title":"Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis","volume":"309","author":"Gunne","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2012.01.007_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nurt.2009.10.021","article-title":"Antioxidant therapies for traumatic brain injury","volume":"7","author":"Hall","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2012.01.007_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2009-0916","article-title":"Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration","volume":"16","author":"Ho","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pbb.2012.01.007_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archpsyc.1979.01780050095012","article-title":"Tardive dyskinesia\u2014reversible and persistent","volume":"36","author":"Jeste","year":"1979","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.01.007_bb0150","first-page":"1485","article-title":"Tardive dyskinesia: epidemiology and clinical presentation","volume":"vol. 39","author":"Kane","year":"1995"},{"key":"10.1016\/j.pbb.2012.01.007_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/archpsyc.1982.04290040069010","article-title":"Tardive dyskinesia: prevalence and risk factors, 1959 to 1979","volume":"39","author":"Kane","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2012.01.007_bb0155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1006\/phrs.1997.0159","article-title":"Neuroleptic drugs alter the dopamine transporter-mediated uptake and release of dopamine: a possible mechanism for drug-induced tardive dyskinesia","volume":"35","author":"Lee","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0160","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/emm.2007.42","article-title":"Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine","volume":"39","author":"Lee","year":"2007","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pbb.2012.01.007_bb0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(87)92878-9","article-title":"Alpha-tocopherol in tardive dyskinesia","volume":"1","author":"Lohr","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2012.01.007_bb0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00023210-200317010-00004","article-title":"Oxidative mechanisms and tardive dyskinesia","volume":"17","author":"Lohr","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2012.01.007_bb0175","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0028-3908(03)00101-1","article-title":"Quercetin, a bioflavonoid, attenuates haloperidol-induced orofacial dyskinesia","volume":"44","author":"Naidu","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2012.01.007_bb0180","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.bcp.2006.11.003","article-title":"Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults","volume":"73","author":"Okawara","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0185","doi-asserted-by":"crossref","unstructured":"Pereira RP, Fachinetto R, de Souza Prestes A, Wagner C, Sudati JH, Boligon AA, et al. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats. J Neural Transm 2011;96:324-32.","DOI":"10.1007\/s00702-011-0640-7"},{"key":"10.1016\/j.pbb.2012.01.007_bb0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0893-133X(01)00364-5","article-title":"Mechanisms underlying the protective potential of alpha-tocopherol (vitamin E) against haloperidol-associated neurotoxicity","volume":"26","author":"Post","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2012.01.007_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050638","article-title":"Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity","volume":"138","author":"Redrobe","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2012.01.007_bb0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.wnf.0000191331.54649.e3","article-title":"A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: implications for tardive dyskinesia","volume":"28","author":"Sadan","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/exnr.1994.1080","article-title":"Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat","volume":"127","author":"Shirakawa","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0076-6879(01)35239-4","article-title":"Absorption of transresveratrol in rats","volume":"335","author":"Soleas","year":"2001","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0215","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0306-4522(00)00412-7","article-title":"Dopamine D1A receptor function in a rodent model of tardive dyskinesia","volume":"101","author":"Van Kampen","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2012.01.007_bb0225","article-title":"Therapeutic potential of resveratrol in Alzheimer's disease","volume":"3","author":"Vingtdeux","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pbb.2012.01.007_bb0220","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(02)03543-6","article-title":"Resveratrol protects against global cerebral ischemic injury in gerbils","volume":"958","author":"Wang","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2012.01.007_bb0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00004714-199102000-00005","article-title":"The prevalence of tardive dyskinesia","volume":"11","author":"Woerner","year":"1991","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2012.01.007_bb0235","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2006.03.190","article-title":"Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity","volume":"344","author":"Y\u00e1\u00f1ez","year":"2006","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305712000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305712000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T19:33:26Z","timestamp":1742326406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305712000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0091305712000081"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2012.01.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}